✦ LIBER ✦

Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: A Hoosier Oncology Group phase II trial

✍ Scribed by Moore, A.M.; Einhorn, L.H.; Estes, D.; Govindan, R.; Axelson, J.; Vinson, J.; Breen, T.E.; Yu, M.; Hanna, N.H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of daily oral VP-16 in re

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II trial of amrubicin and carbopla

✍ Hirose, Takashi; Nakashima, Masanao; Shirai, Takao; Kusumoto, Sojiro; Sugiyama, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Prolonged administration of oral etoposi

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 173 KB

A phase II trial of 6-hydroxymethylacylf

✍ Sherman, Carol A.; Herndon, James E.; Watson, Dorothy M.; Green, Mark R. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 87 KB

186 A phase I/II trial of concurrent che

✍ Landau, D.B.; Miles, E.; Illsley, M.; Laurence, V.; Hughes, S.; Ngai, Y.; Hughes 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

A Phase II trial of carboplatin and vind

✍ Pavlidis, Nicholas A.; Klouvas, George; Nicolaides, Costas; Karantanas, Apostolo 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 354 KB